In Vivo Total Dose Analysis in Mice for BNCT Trial TRIGA Kartini Research Reactor Based Using PHITS
Boron neutron capture therapy (BNCT) is an effective radiotherapy modality to kill cancer. BNCT can selectively kill cancer cells without damaging the healthy tissue around it by using alpha particle and lithium ion from the reaction of 10B(n,α)7Li. These particles have a track of more or less 5 to 9 μm which is the same as the cell diameter. In order to support the development of BNCT in Indonesia an in vivo simulation is performed in a simple mouse geometry containing a 4T1 breast cancer characteristic treated with BNCT using PHITS program. The Neutron source that was used in this simulation was based on TRIGA Kartini Research Reactor. The boron compound concentration in the tumor was varied from 20 ppm up to 90 ppm, and then the total dose was calculated in the mice. Total dose that the tumor received was 0.0161, 0.0168, 0.0175, 0.0182, 0.0185, 0.0188, 0.019, and 0.0191 Gy-Eq/s, respectively and the irradiation time to reach 50 Gy was 51, 50, 48, 46, 45, 45, 44, 44, 40 minutes respectively. This shows that the higher the concentration of boron compound in the tumor the higher the dose that mice received and irradiation time was decreased with the increase of the boron compound concentration.
Emiliano. C. C., Pozzi, Veronica A. Trivillin, et al. 2013, Boron neutron capture therapy (BNCT) for liver metastasis in an experimental model: dose–response at five-week follow-up based on retrospective dose assessment in individual rats., Radiat Environ Biophys., 52:481–491
Carl Ostlund et al., 2005. BNCT in vivo dosimetry: A feasibility study using an HPGe detector for prompt gamma spectroscopy, Med Rad Phy Clinical Sciences, Lund, Lund University. 4-5.
Elisa M. Hebera., M. Frederick Hawthorne., Peter J. Kueffer, Marcela A. Garabalino., Silvia I. Thorp., Emiliano C. C. Pozzi., Andrea Monti Hughes., Charles A. Maitz., Satish S. Jalisatgi., David W. Nigg., Paula Curotto., Verónica A. Trivillin., and Amanda E. Schwint., 2014. Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model. PNAS., 111: 45.
H. Baba., Y. Onizuka., M. Nakao., M. Fukahori., T. Sato., Y. Sakurai., H. Tanaka., and S. Endo., Microdosimetric evaluation of the neutron field for BNCT at Kyoto University Reactor by using the PHITS code., Radiat Prot Dos. 143: 528-532.
ICRU, Tissue Substitutes in Radiation Dosimetry and Measurement, International Commission on Radiation Units and Measurements, Report44, Bethesda, MD (1989).
Kenta Takadaa., Tomonori Isobea., Hiroaki Kumadaa., Tetsuya Yamamotoa., Koichi Shidab., Daisuke Kobayashib., Yutaro Moria., Hideyuki Sakuraia and Takeji Sakae., 2014. Evaluation of the radiation dose for whole body in boron neutron capture therapy. Progress in Nuclear Science and Technology 4: 820-823.
Bailey-Downs LC, Thorpe JE, Disch BC, Bastian A, Hauser PJ, et al. (2014) Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression. PLoS ONE 9(5): e98624.
M. Blaickner., J.V. Kratz., S. Minouchehr., G. Otto., H. Schmidberger., C. Schutz., L. Vogtlander., B. Wortmann., G. Hampel., 2011. Dosimetric feasibility study for an extracorporeal BNCT application on liver metastases at the TRIGA Mainz. Appl. Radiat. Isotopes. 70: 139-143.
M.Ilma Muslih Arrozaqi. (2014). Dasar-Dasar Pemrograman MCNPX. Yogyakarta: Pusat Sains dan Teknologi Akselerator Badan Tenaga Nuklir Nasional.
Minoru Suzuki., Ituro Kato., Teruhito Aihara, Junichi Hiratsuka, Kenichi Yoshimura, Miyuki Niimi, Yoshihiro Kimura., Yasunori Ariyoshi., Shin-ichi Haginomori., Yoshinori Sakurai., Yuko Kinashi., Shin-ichiro Masunaga., Masanori Fukushima., Koji Ono., and Akira Maruhashi., 2014. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. Journal of Rad Res, 55: 146–15.
Monika Puchalska and Lembit Sihver., 2015. PHITS simulations of absorbed dose out-of-feld and neutron energy spectra for ELEKTA SL25 medical linear accelerator. Phys. Med. Biol. 60 N261–270.
Shinji Kawabata, M.D., Ph.D., Ryo Hiramatsu, M.D., Ph.D., Toshihiko Kuroiwa, M.D., Ph.D., Koji ono, M.D., Ph.D., 2013. Boron neutron capture therapy for recurrent high-grade meningiomas. J Neurosurg., 119: 837-844.
V. A. Trivillin., M. A. Garabalino., L.L. Colombo., S.J. González., R.O. Farías ., A. Monti Hughes., E.C.C. Pozzi., S. Bortolussi ., S. Altieri ., M.E. Itoiz., R.F. Aromando., D.W. Nigg ., A.E. Schwint., 2013. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases. Appl. Radiat. Isotopes.
Wolfgang A.G. Sauerwein., Andrea Wittig Raymond Moss., Yoshinobu Nakagawa., 2012. Neutron capture therapy principles and applications. Springer.
Yoshiaki Yura., Yusei Fujita., 2012. Boron neutron capture therapy as a novel modality of radiotherapy for oral cancer: Principle and antitumor effect. Oral Science International., 10: 9-14.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Indonesian Journal of Physics and Nuclear Applications is licensed under a Creative Commons Attribution 4.0 International License.